TY - JOUR
TI - Successful salvage of primary progressive Hodgkin lymphoma with the combination of post-transplant brentuximab vedotin and radiotherapy: Combining novelty and tradition
AU - Belia, M.
AU - Chatzidimitriou, C.
AU - Rondogianni, P.
AU - Petsa, P.
AU - Efstathopoulou, M.
AU - Konstantinou, E.
AU - Arapaki, M.
AU - Asimakopoulos, J.
AU - Plata, E.
AU - Konstantopoulos, K.
AU - Angelopoulou, M.K.
AU - Vassilakopoulos, T.P.
JO - Journal of Hematology & Oncology
PY - 2021
VL - 39
TODO - 2
SP - 258-262
PB - John Wiley and Sons Ltd
SN - 1756-8722
TODO - 10.1002/hon.2801
TODO - bleomycin;  brentuximab vedotin;  busulfan;  cisplatin;  cytarabine;  dacarbazine;  doxorubicin;  etoposide;  gemcitabine;  ifosfamide;  melphalan;  steroid;  vinblastine;  vinorelbine tartrate;  brentuximab vedotin;  immunological antineoplastic agent, adult;  autologous stem cell transplantation;  cancer combination chemotherapy;  cancer radiotherapy;  cancer regression;  case report;  clinical article;  drug megadose;  drug withdrawal;  erythrocyte sedimentation rate;  human;  Letter;  lymphadenopathy;  male;  maximum standardized uptake value;  mediastinum mass;  minimal residual disease;  multiple cycle treatment;  nodular sclerosis Hodgkin lymphoma;  peripheral neuropathy;  positron emission tomography-computed tomography;  primary tumor;  priority journal;  salvage therapy;  treatment response;  autotransplantation;  female;  Hodgkin disease;  multimodality cancer therapy;  pathology;  procedures;  radiotherapy;  salvage therapy;  stem cell transplantation;  treatment outcome, Adult;  Antineoplastic Agents, Immunological;  Brentuximab Vedotin;  Combined Modality Therapy;  Female;  Hodgkin Disease;  Humans;  Male;  Radiotherapy;  Salvage Therapy;  Stem Cell Transplantation;  Transplantation, Autologous;  Treatment Outcome
TODO - null
ER -